{"id":"W4415281009","doi":"10.1016/j.annonc.2025.09.017","title":"ALBAN (GETUG-AFU 37): a phase III, randomized, open-label international trial of intravenous atezolizumab and intravesical Bacillus Calmette–Guérin (BCG) versus BCG alone in BCG-naive high-risk, non-muscle-invasive bladder cancer (NMIBC)","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Institute of Cancer Research; Unicancer; Roche","keywords":"Atezolizumab; Bladder cancer; Bacillus (shape); BCG vaccine; Clinical trial; Phases of clinical research","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001936494,0.002318715,0.001799513,0.0005880534,0.000431569,0.000860507,0.0009478498,0.001477597,0.00512833],"category_scores_gemma":[0.001314687,0.0005161227,0.001299819,0.0003910752,0.001465885,0.0009396976,0.0004687988,0.002717097,0.0008543301],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009349337,"about_ca_system_score_gemma":0.001619241,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00151312,"about_ca_topic_score_gemma":0.003392628,"domain_scores_codex":[0.9995133,0.0002925375,0.00001763105,0.000065647,0.0000307006,0.00008016062],"domain_scores_gemma":[0.999464,0.0001126771,0.0001071299,0.00003305646,0.00002771975,0.0002554811],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9558623,0.01047089,0.0007028335,0.0007231098,0.0004939777,0.00005744542,0.00007175851,0.0006104609,0.004276544,0.0003488017,0.002008623,0.02437319],"study_design_scores_gemma":[0.9313931,0.06553659,0.0009770838,0.00003729096,0.000201516,0.00004786483,0.00001857298,0.0004112684,0.0004160391,0.0001593449,0.0007893661,0.00001189074],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9803357,0.006848686,0.0006763606,0.001290711,0.0005233991,0.004884205,0.001688719,0.0002706669,0.003481488],"genre_scores_gemma":[0.9774413,0.003924294,0.002630609,0.001835034,0.0003913114,0.005876796,0.002687579,0.00004706476,0.005166077],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00512833,"threshold_uncertainty_score":0.01715595,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06096434800192671,"score_gpt":0.4136386297376899,"score_spread":0.3526742817357632,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}